Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Becton, Dickinson and Company

Revenues

Revenues %Chg

Revenues Common Size

Cost of Products Sold

Cost of Products Sold %Chg

Cost of Products Sold Common Size

Selling and Administrative Expense

Selling and Administrative Expense %Chg

Selling and Administrative Expense Common Size

Research and Development Expense

Research and Development Expense %Chg

Research and Development Expense Common Size

Integration, Restructuring and Transaction Expense

Integration, Restructuring and Transaction Expense %Chg

Integration, Restructuring and Transaction Expense Common Size

Other Operating Expense (Income), Net

Other Operating Expense (Income), Net %Chg

Other Operating Expense (Income), Net Common Size

Other Operating Expense, Net

Other Operating Expense, Net %Chg

Other Operating Expense, Net Common Size

Total Operating Costs and Expenses

Total Operating Costs and Expenses %Chg

Total Operating Costs and Expenses Common Size

Operating Income

Operating Income %Chg

Operating Income Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Interest Income

Interest Income %Chg

Interest Income Common Size

Other Income, Net

Other Income, Net %Chg

Other Income, Net Common Size

Income (Loss) Before Income Taxes

Income (Loss) Before Income Taxes %Chg

Income (Loss) Before Income Taxes Common Size

Other Expense, Net

Other Expense, Net %Chg

Other Expense, Net Common Size

Income from Continuing Operations Before Income Taxes

Income from Continuing Operations Before Income Taxes %Chg

Income from Continuing Operations Before Income Taxes Common Size

Income Tax (Benefit) Provision

Income Tax (Benefit) Provision %Chg

Income Tax (Benefit) Provision Common Size

Income Tax Provision (Benefit)

Income Tax Provision (Benefit) %Chg

Income Tax Provision (Benefit) Common Size

Net (Loss) Income

Net (Loss) Income %Chg

Net (Loss) Income Common Size

Income Tax Provision

Income Tax Provision %Chg

Income Tax Provision Common Size

Net Income from Continuing Operations

Net Income from Continuing Operations %Chg

Net Income from Continuing Operations Common Size

Loss from Discontinued Operations, Net of Tax

Loss from Discontinued Operations, Net of Tax %Chg

Loss from Discontinued Operations, Net of Tax Common Size

Income from Discontinued Operations, Net of Tax

Income from Discontinued Operations, Net of Tax %Chg

Income from Discontinued Operations, Net of Tax Common Size

Net Income

Net Income %Chg

Net Income Common Size

Preferred Stock Dividends

Preferred Stock Dividends %Chg

Preferred Stock Dividends Common Size

Net (Loss) Income Applicable to Common Shareholders

Net (Loss) Income Applicable to Common Shareholders %Chg

Net (Loss) Income Applicable to Common Shareholders Common Size

Net Income Applicable to Common Shareholders

Net Income Applicable to Common Shareholders %Chg

Net Income Applicable to Common Shareholders Common Size

Income from Continuing Operations

Income from Continuing Operations %Chg

Income from Continuing Operations Common Size

Loss from Discontinued Operations

Loss from Discontinued Operations %Chg

Loss from Discontinued Operations Common Size

Income from Discontinued Operations

Income from Discontinued Operations %Chg

Income from Discontinued Operations Common Size

Basic Earnings per Share

Basic Earnings per Share %Chg

Basic Earnings per Share Common Size

Diluted Earnings per Share

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Research & Development Expenses

Research & Development Expenses %Chg

Research & Development Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest and Investment Income

Interest and Investment Income %Chg

Interest and Investment Income Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Minority Interests and Other

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Sep '25	Mar '25	Sep '24	Mar '24	Sep '23	Mar '23
Total Revenues	11,400	10,440	10,427	9,751	9,965	9,407
Total Revenues %Chg	9.3%	7.1%	4.6%	3.7%	6%	-0.6%
Revenues
Cost of Sales	5,967	5,948	5,633	5,420	6,164	5,038
Cost of Products Sold
Gross Profit	5,433	4,492	4,794	4,331	3,801	4,369
Gross Profit Margin	47.7%	43%	46%	44.4%	38.1%	46.4%
Selling, General & Administrative Expenses	2,686	2,592	2,451	2,406	2,327	2,392
Selling and Administrative Expense
Research & Development Expenses	619	646	601	589	586	651
Research and Development Expense
Other Operating Expenses	549	255	516	164	-10	113
Integration, Restructuring and Transaction Expense
Other Operating Expense (Income), Net
Other Operating Expense, Net
Operating Profit	1,579	1,000	1,224	1,173	898	1,213
Operating Income
Operating Margin	13.9%	9.6%	11.7%	12%	9%	12.9%
Interest and Investment Income	10	28	103	60	33	16
Interest Income
Interest Expense	-307	-306	-292	-236	-232	-220
Interest Expense
Non-Operating Income	-70	-53	-22	-6	-47	1
Other Income, Net
Other Expense, Net
Total Non-Operating Income	-367	-331	-211	-182	-246	-203
Income Before Provision for Income Taxes	1,212	669	1,014	991	653	1,009
Income (Loss) Before Income Taxes
Provision for Income Taxes	145	58	127	173	92	40
Income Tax (Benefit) Provision
Income Tax Provision (Benefit)
Consolidated Net Income	1,067	611	887	818	515	969
Net Income
Net (Loss) Income
Net Income Attributable to Minority Interests and Other	—	—	—	—	15	45
Preferred Stock Dividends
Net Income Attributable to Preferred Dividends	—	—	—	—	15	45
Preferred Stock Dividends
Net Income Attributable to Discontinued Operations	—	—	—	—	-46	—
Income from Discontinued Operations, Net of Tax
Loss from Discontinued Operations, Net of Tax
Net Income Attributable to Common Shareholders	1,678	611	1,705	818	500	924
Net (Loss) Income Applicable to Common Shareholders
Basic EPS	3.7	2.1	3.1	2.8	1.7	3.3
Diluted EPS	3.7	2.1	3.1	2.8	1.7	3.2
Basic Weighted Average Shares Outstanding	286.9	288.4	289.6	289.9	288.5	284.1
Total Shares Outstanding	285.4	286.6	289.1	289	290.4	284
Diluted Weighted Average Shares Outstanding	287.8	289.2	290.8	291.2	290.8	286
EBITDA	2,826	2,215	2,378	2,305	2,056	2,343
Effective Tax Rate	12%	8.7%	12.5%	17.5%	14.1%	4%